Persistent Asset Partners’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
Other funds holding XENE
Persistent Asset Partners's XENE Position: Q3 2026 in Review
Persistent Asset Partners opened a new position in Xenon Pharmaceuticals (XENE) in Q3 2026: 2,541 shares worth $94.5K. The stake represents 0.03% of the portfolio and ranks #298 among its holdings.
286 funds tracked by Wall St. Rank hold XENE as of Q3 2026.
- Persistent Asset Partners held 2,541 shares of Xenon Pharmaceuticals worth $94.5K as of Q3 2026.
- Xenon Pharmaceuticals was a new Persistent Asset Partners position in Q3 2026.
- Xenon Pharmaceuticals made up 0.03% of Persistent Asset Partners's portfolio in Q3 2026, its #298 holding.
- 286 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q3 2026.
Based on Persistent Asset Partners's 13F filing for Q3 2026, filed 13 Nov 2026.